Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions (NCT00835640)Teva Pharmaceuticals USA2002-01-01
Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions (NCT00833664)Teva Pharmaceuticals USA2002-01-01
Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer (NCT00312429)Duke University2002-01-01
"DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?" (NCT00238641)Stanford University2002-01-01
Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00045136)Poniard Pharmaceuticals2002-01-01
A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy (NCT00407212)Novartis2002-01-01
FR901228 in Treating Patients With Hematologic Cancer (NCT00024180)Ohio State University Comprehensive Cancer Center2002-01-01
Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration (NCT00224536)Hannover Medical School2002-01-01
Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer (NCT00039052)Neurocrine Biosciences2002-01-01
SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors (NCT00015899)Pediatric Brain Tumor Consortium2002-01-01
Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects (NCT02170636)Boehringer Ingelheim2002-01-01
Magnetic Resonance Imaging of Narrowed Arteries (NCT00029575)National Heart, Lung, and Blood Institute (NHLBI)2002-01-01
Reducing Depression in Dementia Caregivers (NCT00056316)University of Missouri, St. Louis2002-01-01
Terbinafine HCl 250 mg Tablet Under Fasting Conditions (NCT00833586)Teva Pharmaceuticals USA2002-01-01
A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx (NCT02055989)Royal Marsden NHS Foundation Trust2002-01-01
Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) (NCT00028236)National Institute of Allergy and Infectious Diseases (NIAID)2001-12-10
Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers (NCT02253823)Boehringer Ingelheim2001-12-01
NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer (NCT00031616)NewBiotics2001-12-01
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine (NCT00074607)Baylor College of Medicine2001-12-01
PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy (NCT01696565)PhytoHealth Corporation2001-12-01
MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery (NCT00027469)National Heart, Lung, and Blood Institute (NHLBI)2001-12-01
Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients (NCT00034255)GMP Endotherapeutics2001-12-01
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors (NCT00030693)National Cancer Institute (NCI)2001-12-01
PP-Gemcitabine & External Beam Radiation-Sarcomas (NCT02046304)M.D. Anderson Cancer Center2001-12-01
Decitabine in Treating Patients With Advanced Solid Tumors (NCT00030615)National Cancer Institute (NCI)2001-12-01
Buspirone Hydrochloride 30mg Tablets, Fasting (NCT00840606)Teva Pharmaceuticals USA2001-12-01
Etoposide and Celecoxib in Patients With Advanced Cancer (NCT00551005)City of Hope Medical Center2001-12-01
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome (NCT00266565)Children's Hospital Medical Center, Cincinnati2001-12-01
R(+)XK469 in Treating Patients With Advanced Neuroblastoma (NCT00028522)National Cancer Institute (NCI)2001-12-01
Glulisine Pre- and Postmeal (NCT00290043)Sanofi2001-12-01
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases (NCT00920972)Washington University School of Medicine2001-12-01
PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00028587)National Cancer Institute (NCI)2001-12-01
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma (NCT00060684)CTI BioPharma2001-12-01
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma (NCT00046852)University of Maryland, Baltimore2001-12-01
Buspirone Hydrochloride 30mg Tablets, Non-Fasting (NCT00840398)Teva Pharmaceuticals USA2001-12-01
Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis (NCT00030381)National Cancer Institute (NCI)2001-12-01
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681)National Cancer Institute (NCI)2001-12-01
Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects (NCT00709254)YM BioSciences2001-12-01
Study of Combination PS-341 and Thalidomide in Multiple Myeloma (NCT00083460)University of Arkansas2001-12-01
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support (NCT00070616)Swedish Orphan Biovitrum2001-12-01
Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS (NCT00079560)National Institute on Drug Abuse (NIDA)2001-12-01
A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus (NCT00873561)Neurocrine Biosciences2001-12-01
HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy (NCT00181506)Maastricht Radiation Oncology2001-12-01
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer (NCT00151086)University of Michigan Rogel Cancer Center2001-12-01
Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer (NCT00028158)MediGene2001-12-01
Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine (NCT00140348)Cell Genesys2001-12-01
Curcumin for the Prevention of Colon Cancer (NCT00027495)University of Michigan Rogel Cancer Center2001-12-01
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498)National Cancer Institute (NCI)2001-12-01
Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma (NCT00306969)Boston University2001-12-01
Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects (NCT00834795)Teva Pharmaceuticals USA2001-12-01
Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD) (NCT00147394)Children's Hospital Medical Center, Cincinnati2001-12-01
Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects (NCT00834873)Teva Pharmaceuticals USA2001-12-01
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 (NCT00033956)MetaPhore Pharmaceuticals2001-12-01
A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach (NCT00038415)M.D. Anderson Cancer Center2001-12-01
Ginkgo Biloba Extract and the Insulin Resistance Syndrome (NCT00032474)National Center for Complementary and Integrative Health (NCCIH)2001-12-01
Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring Method (NCT01058577)Profil Institut für Stoffwechselforschung GmbH2001-12-01
Acute Lung Injury After Allogeneic Transplantation - Diagnosis and Early Treatment (NCT00852605)Technische Universität Dresden2001-12-01
A Study of Mircera in Anemic Patients With Multiple Myeloma (NCT00360347)Hoffmann-La Roche2001-11-29
Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma. (NCT00325416)H. Lee Moffitt Cancer Center and Research Institute2001-11-19
Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer (NCT00158886)GlaxoSmithKline2001-11-08
VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma (NCT00036946)Regeneron Pharmaceuticals2001-11-01
Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110 (NCT00631878)Biosynexus Incorporated2001-11-01
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496)National Cancer Institute (NCI)2001-11-01
Study of Noni in Cancer Patients (NCT00033878)National Center for Complementary and Integrative Health (NCCIH)2001-11-01
Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors (NCT00027027)Genentech, Inc.2001-11-01
Temperature Response to a Head-Neck Cooling System (NCT00025987)National Institute of Neurological Disorders and Stroke (NINDS)2001-11-01
Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00030576)University Health Network, Toronto2001-11-01
Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00045357)Fred Hutchinson Cancer Center2001-11-01
A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers (NCT00480688)University of Oxford2001-11-01
Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection (NCT02226952)Boehringer Ingelheim2001-11-01
Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma (NCT00037011)Memorial Sloan Kettering Cancer Center2001-11-01
Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00028912)Memorial Sloan Kettering Cancer Center2001-11-01
Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma (NCT00036972)Memorial Sloan Kettering Cancer Center2001-11-01
Dose-range Finding Treosulfan-based Conditioning (NCT01063647)medac GmbH2001-11-01
Laser and Medical Treatment of Diabetic Macular Edema (NCT00027287)National Eye Institute (NEI)2001-11-01
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy (NCT00030108)National Institutes of Health Clinical Center (CC)2001-11-01
Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects (NCT01020877)Teva Pharmaceuticals USA2001-11-01
Bioavailability of Oral BIRB 796 BS Tablets With and Without Administration of Oral Pantoprazole in Healthy Male Volunteers (NCT02209831)Boehringer Ingelheim2001-11-01
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors (NCT00028535)National Cancer Institute (NCI)2001-11-01
Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma (NCT00030784)European Organisation for Research and Treatment of Cancer - EORTC2001-11-01
A Phase 1 Study of S-3304 in Patients With Solid Tumors (NCT00033215)Shionogi2001-11-01
Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects (NCT00847925)Renovo2001-11-01
A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma (NCT00215956)H. Lee Moffitt Cancer Center and Research Institute2001-11-01
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies (NCT00215501)Dana-Farber Cancer Institute2001-11-01
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants (NCT00127465)University of Plymouth2001-11-01
ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer (NCT00026364)National Cancer Institute (NCI)2001-11-01
Comparison of the Effect of Tipranavir and Ritonavir or Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Zidovudine in Healthy Volunteers (NCT02249416)Boehringer Ingelheim2001-11-01
Cocaine-Metyrapone Interaction Study - 1 (NCT00033098)National Institute on Drug Abuse (NIDA)2001-11-01
Bortezomib in Treating Children With Advanced Solid Tumors (NCT00021216)National Cancer Institute (NCI)2001-11-01
Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer (NCT00030342)St. Luke's Medical Center2001-11-01
Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers (NCT02180477)Boehringer Ingelheim2001-11-01
Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02194322)Boehringer Ingelheim2001-11-01
Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors (NCT00028405)Light Sciences LLC2001-11-01
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer (NCT00026377)University of Chicago2001-11-01
Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone (NCT00006234)Fred Hutchinson Cancer Center2001-11-01
Vaccine Therapy in Treating Patients With Kidney Cancer (NCT00014131)Lisata Therapeutics, Inc.2001-11-01
Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma (NCT00022555)National Cancer Institute (NCI)2001-11-01
Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00030368)National Cancer Institute (NCI)2001-11-01
G-CSF to Treat Crohn's Disease (NCT00025805)National Institute of Allergy and Infectious Diseases (NIAID)2001-10-23
Treatment for Specific Phobias in Children (NCT00051220)Virginia Polytechnic Institute and State University2001-10-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.